Literature DB >> 23990260

Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.

Rudolf Wolfgang Gasser1.   

Abstract

Primary hyperparathyroidism (PHPT) is the most common cause of hypercalcemia. An autonomous overproduction of parathyroid hormone leading to hypercalcemia, which is not downregulated by the calcium-sensing receptor, is the pathophysiological basis of the disease. The classical manifestations of PHPT include a generalized bone disease, kidney stones, and nephrocalcinosis, gastrointestinal, cardiovascular, neuromuscular and neuropsychiatric symptoms. Recently, the clinical presentation of PHPT, however, has changed in Western countries, it occurs oligo-asymptomatic in up to 80 %. Clinical examination, laboratory, and imaging techniques for the characterization of the disease and the localization include the diagnostic procedure. If possible, parathyroidectomy is the treatment of choice for clinically overt PHPT, for asymptomatic PHPT guidelines were developed in order to decide in individual cases between surgical and conservative approach; this consists of monitoring, adequate calcium and vitamin D intake, as well as hydration. Medical therapy includes bisphosphonates and calcimimetics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23990260     DOI: 10.1007/s10354-013-0235-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  15 in total

Review 1.  Clinical practice. Asymptomatic primary hyperparathyroidism.

Authors:  John P Bilezikian; Shonni J Silverberg
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

Review 2.  Clinical practice. Primary hyperparathyroidism.

Authors:  Claudio Marcocci; Filomena Cetani
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

Review 3.  Diagnosis and management of primary hyperparathyroidism.

Authors:  Shelley Pallan; Mohammed Omair Rahman; Aliya A Khan
Journal:  BMJ       Date:  2012-03-19

4.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

5.  Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism.

Authors:  Mishaela R Rubin; Kristen H Lee; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

6.  Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease.

Authors:  Robert A Wermers; Sundeep Khosla; Elizabeth J Atkinson; Sara J Achenbach; Ann L Oberg; Clive S Grant; L Joseph Melton
Journal:  J Bone Miner Res       Date:  2005-09-19       Impact factor: 6.741

7.  CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism.

Authors:  Gerd Wimmer; Christoph Profanter; Peter Kovacs; Michael Sieb; Michael Gabriel; Daniel Putzer; Reto Bale; Raimund Margreiter; Rupert Prommegger
Journal:  Langenbecks Arch Surg       Date:  2009-08-25       Impact factor: 3.445

8.  Primary hyperparathyroidism: is there an increased prevalence of renal stone disease?

Authors:  Jane M Suh; John J Cronan; Jack M Monchik
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

9.  Virtual neck exploration: a new method for localizing abnormal parathyroid glands.

Authors:  Rupert Prommegger; Gerd Wimmer; Christoph Profanter; Tonja Sauper; Michael Sieb; Peter Kovacs; Reto Bale; Daniel Putzer; Michael Gabriel; Raimund Margreiter
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

Review 10.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

View more
  17 in total

Review 1.  Musculoskeletal manifestations of primary hyperparathyroidism.

Authors:  Ramesh Pappu; Serge A Jabbour; Anthony M Reginato; Antonio J Reginato
Journal:  Clin Rheumatol       Date:  2016-11-04       Impact factor: 2.980

2.  Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?

Authors:  Andreas Kiriakopoulos; Athanasios Petralias; Dimitrios Linos
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 3.  Parathyroidectomy: is vitamin D a player for a good outcome?

Authors:  M Carsote; D N Paduraru; A E Nica; A Valea
Journal:  J Med Life       Date:  2016 Oct-Dec

4.  A Giant-Cell Lesion with Cellular Cannibalism in the Mandible: Case Report and Review of Brown Tumors in Hyperparathyroidism.

Authors:  Lorenzo Azzi; Laura Cimetti; Matteo Annoni; Diego Anselmi; Lucia Tettamanti; Angelo Tagliabue
Journal:  Case Rep Dent       Date:  2017-02-09

5.  Ureteropelvic Junction Obstruction and Parathyroid Adenoma: Coincidence or Link?

Authors:  Salah Termos; Majd AlKabbani; Tim Ulinski; Sami Sanjad; Henri Kotobi; Francois Chalard; Bilal Aoun
Journal:  Case Rep Nephrol       Date:  2017-10-17

6.  Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism.

Authors:  Haoyang Ma; Chun Ouyang; Yaoyu Huang; Changying Xing; Chen Cheng; Wei Liu; Donglan Yuan; Ming Zeng; Xiangbao Yu; Haibin Ren; Yanggang Yuan; Lina Zhang; Fangyan Xu; Ying Cui; Wenkai Ren; Hui Huang; Hanyang Qian; Boqiang Fan; Ningning Wang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

7.  Shear Wave Elastography versus Strain Elastography in Diagnosing Parathyroid Adenomas.

Authors:  Laura Cotoi; Daniela Amzar; Ioan Sporea; Andreea Borlea; Dan Navolan; Flore Varcus; Dana Stoian
Journal:  Int J Endocrinol       Date:  2020-03-17       Impact factor: 3.257

8.  Atypical parathyroid adenoma: clinical and anatomical pathologic features.

Authors:  Alessandro Galani; Riccardo Morandi; Mira Dimko; Sarah Molfino; Carla Baronchelli; Silvia Lai; Federico Gheza; Carlo Cappelli; Claudio Casella
Journal:  World J Surg Oncol       Date:  2021-01-20       Impact factor: 2.754

Review 9.  Primary Hyperparathyroidism.

Authors:  Leonardo Bandeira; John Bilezikian
Journal:  F1000Res       Date:  2016-01-04

10.  Management and outcomes of hyperparathyroidism: a case series from a single institution over two decades.

Authors:  Hassan Al-Thani; Moamena El-Matbouly; Maryam Al-Sulaiti; Mohammad Asim; Ahmad Majzoub; Abdelhakem Tabeb; Ayman El-Menyar
Journal:  Ther Clin Risk Manag       Date:  2018-07-31       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.